Is Sanara Medtech Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 2 Wall Street analysts covering (NASDAQ: SMTI) stock is to Strong Buy SMTI stock.
Out of 2 analysts, 2 (100%) are recommending SMTI as a Strong Buy, 0 (0%) are recommending SMTI as a Buy, 0 (0%) are recommending SMTI as a Hold, 0 (0%) are recommending SMTI as a Sell, and 0 (0%) are recommending SMTI as a Strong Sell.
What is SMTI's forecast return on equity (ROE) for 2023-2023?
(NASDAQ: SMTI) forecast ROE is 2.12%, which is considered weak.
What is SMTI's Price Target?
According to 2 Wall Street analysts that have issued a 1 year SMTI price target, the average SMTI price target is $54.00, with the highest SMTI stock price forecast at $59.00 and the lowest SMTI stock price forecast at $49.00.
On average, Wall Street analysts predict that Sanara Medtech's share price could reach $54.00 by Nov 15, 2024. The average Sanara Medtech stock price prediction forecasts a potential upside of 51.86% from the current SMTI share price of $35.56.
What is SMTI's forecast return on assets (ROA) for 2023-2023?
(NASDAQ: SMTI) forecast ROA is 1.24%, which is lower than the forecast US Medical Instruments & Supplies industry average of 9.11%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.